Jefferies Financial Group Inc.
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 96223
NEW YORK, NY
Position in BMRN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$26,679,282
+$233,715 QoQ
Shares Held
466,258
-0.4% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#63
of 561 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Derivatives in BMRN
reported options exposure · as of Jun 30, 2026CallValue
$858,300
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. BMRN ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,357,042 | $110,693,915 | |
| 2 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $80,947,193 | |
| 3 | IMTX |
Immatics N.V.
|
6,506,802 | $65,913,904 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
2,010,534 | $62,849,292 | |
| 5 | CGON |
CG Oncology, Inc.
|
769,947 | $54,704,734 | |
| 6 | ARGX |
Argenx SE
|
45,068 | $41,812,738 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
929,626 | $31,040,212 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
466,258 | $26,679,282 |
All Filings in BMRN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,679,282 | 466,258 | Shares | Defined | 2026-08-17 | |
| 2026-06-30 | $858,300 | 15,000 | Call | Defined | 2026-08-17 | |
| 2026-03-31 | $26,445,567 | 468,146 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $27,754,879 | 467,018 | Shares | Defined | 2026-02-09 | |
| 2025-03-31 | $436,086 | 6,169 | Shares | Defined | 2025-05-08 | |
| 2024-09-30 | $305,761 | 4,350 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $925,804 | 10,600 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $655,050 | 7,500 | Call | Defined | 2024-05-13 | |
| 2023-12-31 | $3,519,330 | 36,500 | Call | Defined | 2024-05-06 | |
| 2023-12-31 | $985,508 | 10,221 | Shares | Defined | 2024-05-06 | |
| 2023-09-30 | $264,555 | 2,990 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $495,488 | 5,600 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $1,973,104 | 22,300 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $433,400 | 5,000 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | $434,526 | 5,013 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $866,800 | 10,000 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $972,400 | 10,000 | Call | Defined | 2023-05-15 | |
| 2023-03-31 | $972,400 | 10,000 | Put | Defined | 2023-05-15 | |
| 2023-03-31 | $2,714,649 | 27,917 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,736,944 | 45,772 | Shares | Defined | 2023-09-21 | |
| 2022-12-31 | $1,562,699 | 15,100 | Call | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||